Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial:

David P. Nichols, Alex C. Paynter, Sonya L. Heltshe, Scott H. Donaldson, Carla A. Frederick, Steven D. Freedman, Daniel Gelfond, Lucas R. Hoffman, Andrea Kelly, Michael R. Narkewicz, Jessica E. Pittman, Felix Ratjen, Margaret Rosenfeld, Scott D. Sagel, Sarah Jane Schwarzenberg, Pradeep K. Singh, George M. Solomon, Michael S. Stalvey, John P. Clancy, Shannon Kirby, Jill M. Van Dalfsen, Margaret H. Kloster, and Steven M. Rowe; for the PROMISE Study Group..

16 November, 2021

NZ Respiratory Research Review Issue 203

Impact of Time Between Diagnosis and Treatment for Nontuberculous Mycobacterial Pulmonary Disease on Culture Conversion and All-Cause Mortality:

Yunjoo Im, MD, PhD Na Young Hwang, PhD Kyunga Kim, PhD Hojoong Kim, MD, PhD O. Jung Kwon, MD, PhD Byung Woo Jhun, MD, PhD

15 November, 2021

NZ Respiratory Research Review Issue 199

Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study:

Prof Nazir Ahmed Ismail, FCPath, Shaheed Vally Omar, PhD, Harry Moultrie, MBChB, Zaheda Bhyat, BTech, Francesca Conradie, MBChB, M Enwerem, MBBS et al.

12 November, 2021

NZ Respiratory Research Review Issue 199

Molecular Detection of Airborne Mycobacterium tuberculosis in South African High Schools:

Erick W. Bunyasi, Keren Middelkoop, Anastasia Koch, Zeenat Hoosen, Humphrey Mulenga, Angelique K. K. Luabeya, Justin Shenje, Simon C. Mendelsohn, Michele Tameris, Thomas J. Scriba, Digby F. Warner, Robin Wood, Jason R. Andrews, and Mark Hatherill

9 November, 2021

NZ Respiratory Research Review Issue 199

Effects of a Partially Supervised Conditioning Program in Cystic Fibrosis: An International Multicenter, Randomized Controlled Trial (ACTIVATE-CF):

Helge Hebestreit, Susi Kriemler, Christian Schindler, Lothar Stein, Chantal Karila, Don S. Urquhart, David M. Orenstein, Larry C. Lands, Jonathan Schaeff, Ernst Eber, and Thomas Radtke; on behalf of the ACTIVATE-CF Study Working Group

4 November, 2021

NZ Respiratory Research Review Issue 203

Lung Microenvironments and Disease Progression in Fibrotic Hypersensitivity Pneumonitis:

Laurens J. De Sadeleer, John E. McDonough, Jonas C. Schupp, Xiting Yan, Arno Vanstapel, Anke Van Herck, Stephanie Everaerts, Vincent Geudens, Annelore Sacreas, Tinne Goos, Celine Aelbrecht

1 November, 2021

NZ Respiratory Research Review Issue 201

Anxiety and Depression in Patients With Nontuberculous Mycobacterial Pulmonary Disease - A Prospective Cohort Study in South Korea:

Hae In Jung, MD Sung A Kim, RN Hyung-Jun Kim, MD Jae-Joon Yim, MD Nakwon Kwak, MD

28 October, 2021

NZ Respiratory Research Review Issue 199

Risk factors for chronic cough in adults: A systematic review and meta-analysis:

Jingwen Zhang,Jennifer L. Perret,Anne B. Chang,Nur S. Idrose,Dinh S. Bui,Adrian J. Lowe,Michael J. Abramson,E. Haydn Walters,Caroline J. Lodge,Shyamali C. Dharmage

18 October, 2021

NZ Respiratory Research Review Issue 203

Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised, non-inferiority, antimicrobial stewardship intervention trial:

Valentijn A Schweitzer, MD, Inger van Heijl, PharmD, Wim G Boersma, MD Wouter Rozemeijer, MD Kees Verduin, MD Marco J Grootenboers, MD et al

7 October, 2021

NZ Respiratory Research Review Issue 196

Chronic thromboembolic pulmonary hypertension in Australia and New Zealand: An analysis of the PHSANZ registry:

Katherine Kearney,Joshua Gold,Carolyn Corrigan,Kumud Dhital,David Boshell,David Haydock,David McGiffin,Michael Wilson,Nicholas Collins,Rachael Cordina,Nathan Dwyer,John Feenstra,Melanie Lavender,Jeremy Wrobel,Helen Whitford,Trevor Williams,Dominic Keating,Ken Whyte,Tanya McWilliams,Anne Keogh,Geoff Strange,Eugene Kotlyar,James Anderson,Edmund MT Lau

5 October, 2021

NZ Respiratory Research Review Issue 195